Meta Pixel

News and Announcements

Focus – Recent VC funding in Europe

  • Published December 20, 2022 4:59AM UTC
  • Publisher Callum Melrose
  • Categories Capital Raising Tips

In recent years, early stage funding in Europe has weakened significantly. A key reason for this is the lack of availability of venture capital.

⬇️

Venture capital is an important source of financing for early stage companies. It allows entrepreneurs to raise the money they need to start and grow their businesses. However, venture capitalists typically get involved much later in the cycle and invest in high-growth companies. As a result, there is a lack of investment in lower-growth or early stage companies.

This situation has led to the closure of many early stage businesses in Europe. It also makes it difficult for new businesses to get started and compete with the established players.

There are several solutions to this problem. First, the government could provide more funding for venture capital. This would allow more low-growth companies to get started and grow. Second, the banks could start lending to early stage companies. This would help them to develop and expand their businesses.

Finally, there are initiatives being undertaken by the private sector to address this issue. For example, there are now more incubators and accelerators in Europe that provide support to early stage companies.

Another solution, is the rise of the angel and high net worth investors. These investors are typically more interested in investing in early stage companies, as they buy into the team and the vision. The rise of these types of investors is a positive trend. It indicates that there is growing interest in investing in early stage companies.

Overall, the lack of availability of venture capital is a major weakness in the European economy. It has led to the closure of many businesses and made it difficult for new entrants to compete. Hopefully, these solutions will help to address the problem. Thank you for your time. I hope this has been helpful. If not, please let me know and I will do my best to help you further.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now